Net Worth Advisory Group Astrazeneca PLC Transaction History
Net Worth Advisory Group
- $329 Billion
- Q4 2024
A detailed history of Net Worth Advisory Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Net Worth Advisory Group holds 4,591 shares of AZN stock, worth $344,003. This represents 0.09% of its overall portfolio holdings.
Number of Shares
4,591
Previous 4,696
2.24%
Holding current value
$344,003
Previous $366 Million
17.78%
% of portfolio
0.09%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,368Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.52 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.07 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.81 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.78 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.8 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $232B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...